<DOC>
	<DOCNO>NCT02545231</DOCNO>
	<brief_summary>To compare low dose ( 1mg ) pitavastatin high dose ( 4mg ) pitavastatin neointimal hyperplasia atherosclerosis progression use optical coherence tomography ( OCT ) near-infrared spectroscopy ( NIRS ) 12 month follow-up clinical adverse cardiovascular event 3-year follow-up .</brief_summary>
	<brief_title>Effect Low-dose vs. High-dose Pitavastatin In-stent Restenosis</brief_title>
	<detailed_description>- Patients non-ST elevation ACS randomize pitavastatin 1mg 4mg everolimus-eluting stent implantation OCT NIRS study . - 12 month follow-up coronary angiography OCT NIRS perform compare neointimal hyperplasia atherosclerosis progression . - 36 month clinical follow-up major adverse cardiovascular event ( cardiac death , all-cause death , myocardial infarction , stroke , target lesion revascularization ) compare . - Safety issue bleed rate , abnormal liver function compare</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Neointima</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>1 . Provision inform consent prior study specific procedures 2 . Patients age 30 79 3 . NonST elevation Acute coronary syndrome successful everolimus elute stent implantation ( TIMI flow grade 3 procedure ) 1 . Hypersensitivity pitavastatin 2 . Unable perform OCT NIRS 3 . Serum creatinine &gt; 2.0 mg/dL . 4 . Steroid hormone replacement therapy 5 . Hemoglobin A1c &gt; 9 % 6 . Type 1 diabetes 7 . Decreased serum platelet level ( &lt; 100,000/uL ) 8 . Need chronic oral anticoagulant therapy chronic lowmolecularweight heparin 9 . Life expectancy less year 10 . Renal failure require dialysis anticipate need dialysis course study 11 . Any condition opinion investigator would make unsafe unsuitable patient participate study 12 . Involvement plan and/or conduct study 13 . Left ventricular ejection fraction &lt; 40 % 14 . Hepatic dysfunction ( aspartate aminotransferase alanine aminotransferase &gt; twice upper limit ) 15 . Gastrointestinal disorder Crohn ` disease 16 . Alcohol abuse 17 . Known pregnancy , breastfeeding , intend become pregnant study period</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>